AU707892B2 - Methods of inhibiting colon tumors - Google Patents

Methods of inhibiting colon tumors Download PDF

Info

Publication number
AU707892B2
AU707892B2 AU21239/97A AU2123997A AU707892B2 AU 707892 B2 AU707892 B2 AU 707892B2 AU 21239/97 A AU21239/97 A AU 21239/97A AU 2123997 A AU2123997 A AU 2123997A AU 707892 B2 AU707892 B2 AU 707892B2
Authority
AU
Australia
Prior art keywords
compound
formula
cancer
colon cancer
raloxifene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU21239/97A
Other languages
English (en)
Other versions
AU2123997A (en
Inventor
Maria L. Brandi
Francesco Tonelli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9603150.5A external-priority patent/GB9603150D0/en
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of AU2123997A publication Critical patent/AU2123997A/en
Application granted granted Critical
Publication of AU707892B2 publication Critical patent/AU707892B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
AU21239/97A 1996-01-29 1997-01-27 Methods of inhibiting colon tumors Ceased AU707892B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US1077296P 1996-01-29 1996-01-29
US60/010772 1996-01-29
GB96/03150 1996-02-15
GBGB9603150.5A GB9603150D0 (en) 1996-02-15 1996-02-15 Methods of inhibiting colon tumors
PCT/US1997/002286 WO1997026877A1 (en) 1996-01-29 1997-01-27 Methods of inhibiting colon tumors

Publications (2)

Publication Number Publication Date
AU2123997A AU2123997A (en) 1997-08-20
AU707892B2 true AU707892B2 (en) 1999-07-22

Family

ID=26308709

Family Applications (1)

Application Number Title Priority Date Filing Date
AU21239/97A Ceased AU707892B2 (en) 1996-01-29 1997-01-27 Methods of inhibiting colon tumors

Country Status (19)

Country Link
EP (1) EP0921799A4 (he)
JP (1) JP2000503994A (he)
KR (1) KR19990082054A (he)
CN (1) CN1209745A (he)
AR (1) AR010978A1 (he)
AU (1) AU707892B2 (he)
BR (1) BR9700778A (he)
CO (1) CO4761062A1 (he)
CZ (1) CZ235498A3 (he)
EA (1) EA001104B1 (he)
ID (1) ID15917A (he)
IL (1) IL125521A (he)
MX (1) MX9806036A (he)
NO (1) NO983451D0 (he)
NZ (1) NZ331105A (he)
PL (1) PL328147A1 (he)
TW (1) TW446560B (he)
WO (1) WO1997026877A1 (he)
YU (1) YU2397A (he)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW366342B (en) * 1992-07-28 1999-08-11 Lilly Co Eli The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
KR950010891A (ko) * 1993-10-15 1995-05-15 피터 지. 스트링거 내성 종양을 치료하는 방법
US5574047A (en) * 1993-12-21 1996-11-12 Eli Lilly And Company Methods of inhibiting imperfect tissue repair

Also Published As

Publication number Publication date
EA199800677A1 (ru) 1999-02-25
NO983451L (no) 1998-07-27
EA001104B1 (ru) 2000-10-30
KR19990082054A (ko) 1999-11-15
YU2397A (en) 1999-11-22
ID15917A (id) 1997-08-21
CO4761062A1 (es) 1999-04-27
MX9806036A (es) 1998-11-29
IL125521A0 (en) 1999-03-12
CN1209745A (zh) 1999-03-03
PL328147A1 (en) 1999-01-18
EP0921799A4 (en) 2002-03-13
IL125521A (he) 2001-11-25
JP2000503994A (ja) 2000-04-04
EP0921799A1 (en) 1999-06-16
AR010978A1 (es) 2000-08-02
CZ235498A3 (cs) 1999-02-17
BR9700778A (pt) 1998-10-06
AU2123997A (en) 1997-08-20
NO983451D0 (no) 1998-07-27
NZ331105A (en) 2000-06-23
TW446560B (en) 2001-07-21
WO1997026877A1 (en) 1997-07-31

Similar Documents

Publication Publication Date Title
US5604248A (en) Method for minimizing the uterotrophic effect of tamoxifen and tamoxifen analogs
AU691844B2 (en) Methods for inhibiting vasomotor symptoms and attending psychological disturbances surrounding post-menopausal syndrome
AU698389B2 (en) Methods for inhibiting LDL oxidation and atheroclerosis
PT652000E (pt) Metodos para a inibicao de angiogenese e doencas angiogenicas
AU701701B2 (en) Methods of inhibiting breast disorders
US5451590A (en) Methods of inhibiting sexual precocity
US5843974A (en) Methods of inhibiting melanoma using Benzothiophenes as cytotoxic agents per se
CA2138494A1 (en) Methods of inhibiting turner's syndrome
MXPA97009466A (en) Medicine to inhibit the melan
AU707892B2 (en) Methods of inhibiting colon tumors
US5670523A (en) Methods of inhibiting musculoaponeurotic fibromatoses (desmoid tumors)
AU707675B2 (en) Methods of inhibiting musculoaponeurotic fibromatoses (desmoid tumors)
CA2244112A1 (en) Methods of inhibiting colon tumors
NZ292017A (en) Use of raloxifene to treat endometrial cancer
EP0729755A2 (en) 2-Phenyl-3-aroylbenziothiophenen for inhibiting ovarian cancer
EP0729754A2 (en) 2-Phenyl-3-aroylbonzothiophenes for inhibiting estrogen positive tumors of the brain or CNS
CA2244247A1 (en) Methods of inhibiting musculoaponeurotic fibromatoses (desmoid tumors)

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired